JOSE MARIA EIROS BOUZA-rekin lankidetzan egindako argitalpenak (36)

2023

  1. Effect of viral storm in patients admitted to intensive care units with severe COVID-19 in Spain: a multicentre, prospective, cohort study

    The Lancet Microbe, Vol. 4, Núm. 6, pp. e431-e441

2022

  1. Crispr/casrx proof-of-concept for rna degradation: A future tool against rna viruses?

    Pharmaceuticals, Vol. 15, Núm. 1

  2. Low anti-SARS-CoV-2 S antibody levels predict increased mortality and dissemination of viral components in the blood of critical COVID-19 patients

    Journal of Internal Medicine, Vol. 291, Núm. 2, pp. 232-240

  3. N-antigenemia detection by a rapid lateral flow test predicts 90-day mortality in COVID-19: A prospective cohort study

    Clinical Microbiology and Infection, Vol. 28, Núm. 10, pp. 1391.e1-1391.e5

2021

  1. Combining immunomodulators and antivirals for COVID-19 – Authors' reply

    The Lancet Microbe

  2. Comparison of real-time and droplet digital PCR to detect and quantify SARS-CoV-2 RNA in plasma

    European Journal of Clinical Investigation, Vol. 51, Núm. 6

  3. Evaluation of cytokines as robust diagnostic biomarkers for COVID-19 detection

    Journal of Personalized Medicine, Vol. 11, Núm. 7

  4. Mounting evidence of impaired viral control in severe COVID-19

    The Lancet Microbe

2020

  1. Viral RNA load in plasma is associated with critical illness and a dysregulated host response in COVID-19

    Critical Care, Vol. 24, Núm. 1

2018

  1. Minimización de errores preanalíticos y su repercusión en el control del laboratorio clínico

    Revista del Laboratorio Clinico

  2. Minimización de errores preanalíticos y su repercusión en el control del laboratorio clínico

    Revista del laboratorio clínico, Vol. 11, Núm. 1, pp. 51-58

2016

  1. Defining immunological dysfunction in sepsis: A requisite tool for precision medicine

    Journal of Infection, Vol. 72, Núm. 5, pp. 525-536

  2. Deletion of FAST (Fas-activated serine/threonine phosphoprotein) ameliorates immune complex arthritis in mice

    Modern Rheumatology, Vol. 26, Núm. 4, pp. 630-632

  3. Postbooster antibodies from humans as source of diphtheria antitoxin

    Emerging Infectious Diseases, Vol. 22, Núm. 7, pp. 1265-1267

  4. ¿tendencia hacia el laboratorio a tiempo real "online", hospital sin papeles?

    Gaceta Medica de Bilbao, Vol. 113, Núm. 4, pp. 176-182

2015

  1. Preventing sepsis

    The Lancet Infectious Diseases

  2. The original sins of clinical trials with intravenous immunoglobulins in sepsis

    Critical Care

  3. Transcriptomic correlates of organ failure extent in sepsis

    Journal of Infection, Vol. 70, Núm. 5, pp. 445-456

  4. ¿tendencia hacia el laboratorio a tiempo real "online", hospital sin papeles?

    Gaceta Medica de Bilbao, Vol. 112, Núm. 4, pp. 176-182

2014

  1. Hyperimmune serum from healthy vaccinated individuals for Ebola virus disease?

    The Lancet Global Health